SELLAS Life Sciences Group Inc (SLS)
1.63
+0.09
(+5.84%)
USD |
NASDAQ |
Apr 23, 16:00
1.64
+0.01
(+0.61%)
After-Hours: 20:00
SELLAS Life Sciences Group Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 29, 2023 | 9.600 |
| September 28, 2023 | 9.775 |
| September 27, 2023 | 10.65 |
| September 26, 2023 | 10.01 |
| September 25, 2023 | 8.956 |
| September 22, 2023 | 8.839 |
| September 21, 2023 | 9.365 |
| September 20, 2023 | 8.780 |
| September 19, 2023 | 8.780 |
| September 18, 2023 | 8.780 |
| September 15, 2023 | 9.424 |
| September 14, 2023 | 8.839 |
| September 13, 2023 | 8.897 |
| September 12, 2023 | 8.839 |
| September 11, 2023 | 8.839 |
| September 08, 2023 | 9.307 |
| September 07, 2023 | 8.604 |
| September 06, 2023 | 8.400 |
| September 05, 2023 | 8.429 |
| September 01, 2023 | 8.780 |
| August 31, 2023 | 8.604 |
| August 30, 2023 | 8.487 |
| August 29, 2023 | 8.572 |
| August 28, 2023 | 8.590 |
| August 25, 2023 | 8.722 |
| Date | Value |
|---|---|
| August 24, 2023 | 8.780 |
| August 23, 2023 | 8.722 |
| August 22, 2023 | 8.663 |
| August 21, 2023 | 8.663 |
| August 18, 2023 | 8.839 |
| August 17, 2023 | 8.312 |
| August 16, 2023 | 8.312 |
| August 15, 2023 | 8.722 |
| August 14, 2023 | 8.897 |
| August 11, 2023 | 9.065 |
| August 10, 2023 | 9.190 |
| August 09, 2023 | 9.190 |
| August 08, 2023 | 9.248 |
| August 07, 2023 | 9.044 |
| August 04, 2023 | 8.956 |
| August 03, 2023 | 9.482 |
| August 02, 2023 | 9.248 |
| August 01, 2023 | 9.600 |
| July 31, 2023 | 9.600 |
| July 28, 2023 | 9.717 |
| July 27, 2023 | 9.014 |
| July 26, 2023 | 9.600 |
| July 25, 2023 | 9.307 |
| July 24, 2023 | 9.629 |
| July 21, 2023 | 9.892 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.8031
Minimum
Jul 01 2019
26.40
Maximum
Mar 31 2022
5.304
Average
4.141
Median
Price to Book Value Benchmarks
| Geron Corp | 7.708 |
| Immuneering Corp | 0.5237 |
| Protagonist Therapeutics Inc | 4.642 |
| Akebia Therapeutics Inc | -- |
| Moderna Inc | 2.982 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0203 |
| Price | 1.63 |
| Earnings Yield | -83.44% |
| Market Cap | 91.72M |
| PEGY Ratio | -0.0203 |